Chemomab Therapeutics Ltd ADR (NASDAQ: CMMB) kicked off on November 20, 2023, at the price of $0.56, down -12.16% from the previous trading day. During the day, the shares moved up to $0.5656 and dropped to $0.4301 before settling in for the closing price of $0.57. Over the past 52 weeks, CMMB has traded in a range of $0.50-$5.35.
Elon Musk just Triggered a BOOM in These Stocks
Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"
Click Here to Download the FREE Report.
Sponsored
While this was happening, its average annual earnings per share was recorded -12.50%. With a float of $10.05 million, this company’s outstanding shares have now reached $11.63 million.
Let’s look at the performance matrix of the company that is accounted for 37 employees.
Chemomab Therapeutics Ltd ADR (CMMB) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Chemomab Therapeutics Ltd ADR is 18.96%, while institutional ownership is 2.42%. The most recent insider transaction that took place on Jan 03, was worth 1,207,759. In this transaction 10% Owner of this company sold 336,900 shares at a rate of $3.58, taking the stock ownership to the 2,241,274 shares. Before that another transaction happened on Jan 03, when Company’s Chief Scientific Officer sold 7,700 for $5.03, making the entire transaction worth $38,706. This insider now owns 317,075 shares in total.
Chemomab Therapeutics Ltd ADR (CMMB) Performance Highlights and Predictions
This company achieved a return on equity of -56.38. Wall Street market experts anticipate that the next fiscal year will bring earnings of 4.21 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -12.50% per share during the next fiscal year.
Chemomab Therapeutics Ltd ADR (NASDAQ: CMMB) Trading Performance Indicators
Take a look at Chemomab Therapeutics Ltd ADR’s (CMMB) current performance indicators. Last quarter, stock had a quick ratio of 4.16.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.55, a number that is poised to hit -0.03 in the next quarter and is forecasted to reach -0.10 in one year’s time.
Technical Analysis of Chemomab Therapeutics Ltd ADR (CMMB)
Chemomab Therapeutics Ltd ADR (NASDAQ: CMMB) saw its 5-day average volume 16.18 million, a positive change from its year-to-date volume of 0.67 million. As of the previous 9 days, the stock’s Stochastic %D was 16.76%. Additionally, its Average True Range was 0.12.
During the past 100 days, Chemomab Therapeutics Ltd ADR’s (CMMB) raw stochastic average was set at 6.53%, which indicates a significant decrease from 10.76% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 184.39% in the past 14 days, which was higher than the 86.51% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8305, while its 200-day Moving Average is $1.3365. Nevertheless, the first resistance level for the watch stands at $0.5670 in the near term. At $0.6341, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.7025. If the price goes on to break the first support level at $0.4315, it is likely to go to the next support level at $0.3631. Assuming the price breaks the second support level, the third support level stands at $0.2960.
Chemomab Therapeutics Ltd ADR (NASDAQ: CMMB) Key Stats
The company with the Market Capitalisation of 6.20 million has total of 11,050K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -27,650 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -4,080 K.